Dermira Reports First Quarter 2019 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Dermira (DERM) Tops Q1 EPS by 13c
May 7, 2019 4:37 PM EDTDermira (NASDAQ: DERM) reported Q1 EPS of ($1.49), $0.13 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.64 million.
Positive momentum continued into the first quarter 2019 at Dermira. Bolstered by significant prescription growth of QBREXZA... More
